nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—Melatonin—MT3—lung cancer	0.0106	0.559	CrCbGaD
Rizatriptan—Sumatriptan—ABCG2—lung cancer	0.00299	0.158	CrCbGaD
Rizatriptan—Almotriptan—CYP2E1—lung cancer	0.00247	0.13	CrCbGaD
Rizatriptan—Melatonin—CYP1A1—lung cancer	0.00165	0.0869	CrCbGaD
Rizatriptan—Sumatriptan—ABCB1—lung cancer	0.00125	0.0658	CrCbGaD
Rizatriptan—Hyperhidrosis—Paclitaxel—lung cancer	0.00044	0.000563	CcSEcCtD
Rizatriptan—Nasopharyngitis—Doxorubicin—lung cancer	0.000438	0.000561	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Cisplatin—lung cancer	0.000438	0.00056	CcSEcCtD
Rizatriptan—Anorexia—Paclitaxel—lung cancer	0.000434	0.000556	CcSEcCtD
Rizatriptan—Gastritis—Doxorubicin—lung cancer	0.000434	0.000555	CcSEcCtD
Rizatriptan—Pain—Cisplatin—lung cancer	0.000434	0.000555	CcSEcCtD
Rizatriptan—Muscular weakness—Doxorubicin—lung cancer	0.000432	0.000553	CcSEcCtD
Rizatriptan—Vomiting—Vinorelbine—lung cancer	0.000431	0.000551	CcSEcCtD
Rizatriptan—Body temperature increased—Gemcitabine—lung cancer	0.00043	0.00055	CcSEcCtD
Rizatriptan—Rash—Vinorelbine—lung cancer	0.000427	0.000546	CcSEcCtD
Rizatriptan—Dermatitis—Vinorelbine—lung cancer	0.000427	0.000546	CcSEcCtD
Rizatriptan—Abdominal distension—Doxorubicin—lung cancer	0.000427	0.000546	CcSEcCtD
Rizatriptan—Headache—Vinorelbine—lung cancer	0.000424	0.000543	CcSEcCtD
Rizatriptan—Syncope—Docetaxel—lung cancer	0.000424	0.000543	CcSEcCtD
Rizatriptan—Dysphagia—Doxorubicin—lung cancer	0.000424	0.000542	CcSEcCtD
Rizatriptan—Sweating—Methotrexate—lung cancer	0.000418	0.000535	CcSEcCtD
Rizatriptan—Palpitations—Docetaxel—lung cancer	0.000418	0.000535	CcSEcCtD
Rizatriptan—Feeling abnormal—Cisplatin—lung cancer	0.000418	0.000535	CcSEcCtD
Rizatriptan—Paraesthesia—Etoposide—lung cancer	0.000417	0.000534	CcSEcCtD
Rizatriptan—Loss of consciousness—Docetaxel—lung cancer	0.000416	0.000532	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000415	0.000531	CcSEcCtD
Rizatriptan—Dyspnoea—Etoposide—lung cancer	0.000414	0.00053	CcSEcCtD
Rizatriptan—Somnolence—Etoposide—lung cancer	0.000413	0.000529	CcSEcCtD
Rizatriptan—Cough—Docetaxel—lung cancer	0.000413	0.000528	CcSEcCtD
Rizatriptan—Angina pectoris—Doxorubicin—lung cancer	0.000413	0.000528	CcSEcCtD
Rizatriptan—Insomnia—Paclitaxel—lung cancer	0.000412	0.000527	CcSEcCtD
Rizatriptan—Epistaxis—Methotrexate—lung cancer	0.000412	0.000527	CcSEcCtD
Rizatriptan—Hypersensitivity—Irinotecan—lung cancer	0.000412	0.000527	CcSEcCtD
Rizatriptan—Convulsion—Docetaxel—lung cancer	0.00041	0.000525	CcSEcCtD
Rizatriptan—Paraesthesia—Paclitaxel—lung cancer	0.000409	0.000523	CcSEcCtD
Rizatriptan—Hypertension—Docetaxel—lung cancer	0.000408	0.000523	CcSEcCtD
Rizatriptan—Dyspnoea—Paclitaxel—lung cancer	0.000406	0.00052	CcSEcCtD
Rizatriptan—Somnolence—Paclitaxel—lung cancer	0.000405	0.000518	CcSEcCtD
Rizatriptan—Decreased appetite—Etoposide—lung cancer	0.000404	0.000517	CcSEcCtD
Rizatriptan—Arthralgia—Docetaxel—lung cancer	0.000403	0.000515	CcSEcCtD
Rizatriptan—Chest pain—Docetaxel—lung cancer	0.000403	0.000515	CcSEcCtD
Rizatriptan—Myalgia—Docetaxel—lung cancer	0.000403	0.000515	CcSEcCtD
Rizatriptan—Nausea—Vinorelbine—lung cancer	0.000402	0.000515	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Etoposide—lung cancer	0.000401	0.000513	CcSEcCtD
Rizatriptan—Dyspepsia—Paclitaxel—lung cancer	0.000401	0.000513	CcSEcCtD
Rizatriptan—Body temperature increased—Cisplatin—lung cancer	0.000401	0.000513	CcSEcCtD
Rizatriptan—Asthenia—Irinotecan—lung cancer	0.000401	0.000513	CcSEcCtD
Rizatriptan—Fatigue—Etoposide—lung cancer	0.000401	0.000513	CcSEcCtD
Rizatriptan—Constipation—Etoposide—lung cancer	0.000397	0.000508	CcSEcCtD
Rizatriptan—Pain—Etoposide—lung cancer	0.000397	0.000508	CcSEcCtD
Rizatriptan—Dysuria—Doxorubicin—lung cancer	0.000396	0.000507	CcSEcCtD
Rizatriptan—Decreased appetite—Paclitaxel—lung cancer	0.000396	0.000507	CcSEcCtD
Rizatriptan—Dry mouth—Docetaxel—lung cancer	0.000394	0.000504	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000394	0.000504	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000393	0.000503	CcSEcCtD
Rizatriptan—Fatigue—Paclitaxel—lung cancer	0.000393	0.000503	CcSEcCtD
Rizatriptan—Pollakiuria—Doxorubicin—lung cancer	0.000391	0.000501	CcSEcCtD
Rizatriptan—Asthenia—Gemcitabine—lung cancer	0.00039	0.0005	CcSEcCtD
Rizatriptan—Pain—Paclitaxel—lung cancer	0.00039	0.000498	CcSEcCtD
Rizatriptan—Constipation—Paclitaxel—lung cancer	0.00039	0.000498	CcSEcCtD
Rizatriptan—Confusional state—Docetaxel—lung cancer	0.000389	0.000498	CcSEcCtD
Rizatriptan—Pharyngitis—Methotrexate—lung cancer	0.000389	0.000497	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Doxorubicin—lung cancer	0.000387	0.000495	CcSEcCtD
Rizatriptan—Anaphylactic shock—Docetaxel—lung cancer	0.000386	0.000494	CcSEcCtD
Rizatriptan—Oedema—Docetaxel—lung cancer	0.000386	0.000494	CcSEcCtD
Rizatriptan—Pruritus—Gemcitabine—lung cancer	0.000385	0.000493	CcSEcCtD
Rizatriptan—Feeling abnormal—Etoposide—lung cancer	0.000383	0.00049	CcSEcCtD
Rizatriptan—Diarrhoea—Irinotecan—lung cancer	0.000382	0.000489	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Etoposide—lung cancer	0.00038	0.000486	CcSEcCtD
Rizatriptan—Shock—Docetaxel—lung cancer	0.00038	0.000486	CcSEcCtD
Rizatriptan—Nervous system disorder—Docetaxel—lung cancer	0.000379	0.000485	CcSEcCtD
Rizatriptan—Tachycardia—Docetaxel—lung cancer	0.000377	0.000482	CcSEcCtD
Rizatriptan—Feeling abnormal—Paclitaxel—lung cancer	0.000375	0.00048	CcSEcCtD
Rizatriptan—Hypersensitivity—Cisplatin—lung cancer	0.000374	0.000478	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Paclitaxel—lung cancer	0.000373	0.000477	CcSEcCtD
Rizatriptan—Diarrhoea—Gemcitabine—lung cancer	0.000372	0.000476	CcSEcCtD
Rizatriptan—Dizziness—Irinotecan—lung cancer	0.000369	0.000473	CcSEcCtD
Rizatriptan—Urticaria—Etoposide—lung cancer	0.000369	0.000472	CcSEcCtD
Rizatriptan—Anorexia—Docetaxel—lung cancer	0.000368	0.000471	CcSEcCtD
Rizatriptan—Abdominal pain—Etoposide—lung cancer	0.000367	0.00047	CcSEcCtD
Rizatriptan—Body temperature increased—Etoposide—lung cancer	0.000367	0.00047	CcSEcCtD
Rizatriptan—Tinnitus—Methotrexate—lung cancer	0.000365	0.000467	CcSEcCtD
Rizatriptan—Asthenia—Cisplatin—lung cancer	0.000364	0.000466	CcSEcCtD
Rizatriptan—Sweating—Doxorubicin—lung cancer	0.000362	0.000463	CcSEcCtD
Rizatriptan—Urticaria—Paclitaxel—lung cancer	0.000362	0.000463	CcSEcCtD
Rizatriptan—Abdominal pain—Paclitaxel—lung cancer	0.00036	0.000461	CcSEcCtD
Rizatriptan—Body temperature increased—Paclitaxel—lung cancer	0.00036	0.000461	CcSEcCtD
Rizatriptan—Epistaxis—Doxorubicin—lung cancer	0.000356	0.000456	CcSEcCtD
Rizatriptan—Angiopathy—Methotrexate—lung cancer	0.000355	0.000455	CcSEcCtD
Rizatriptan—Vomiting—Irinotecan—lung cancer	0.000355	0.000454	CcSEcCtD
Rizatriptan—Rash—Irinotecan—lung cancer	0.000352	0.000451	CcSEcCtD
Rizatriptan—Dermatitis—Irinotecan—lung cancer	0.000352	0.00045	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000352	0.00045	CcSEcCtD
Rizatriptan—Chills—Methotrexate—lung cancer	0.000351	0.00045	CcSEcCtD
Rizatriptan—Headache—Irinotecan—lung cancer	0.00035	0.000448	CcSEcCtD
Rizatriptan—Insomnia—Docetaxel—lung cancer	0.000349	0.000447	CcSEcCtD
Rizatriptan—Diarrhoea—Cisplatin—lung cancer	0.000347	0.000444	CcSEcCtD
Rizatriptan—Paraesthesia—Docetaxel—lung cancer	0.000347	0.000444	CcSEcCtD
Rizatriptan—Vomiting—Gemcitabine—lung cancer	0.000346	0.000443	CcSEcCtD
Rizatriptan—Bradycardia—Doxorubicin—lung cancer	0.000345	0.000442	CcSEcCtD
Rizatriptan—Dyspnoea—Docetaxel—lung cancer	0.000344	0.00044	CcSEcCtD
Rizatriptan—Somnolence—Docetaxel—lung cancer	0.000343	0.000439	CcSEcCtD
Rizatriptan—Mental disorder—Methotrexate—lung cancer	0.000343	0.000439	CcSEcCtD
Rizatriptan—Rash—Gemcitabine—lung cancer	0.000343	0.000439	CcSEcCtD
Rizatriptan—Dermatitis—Gemcitabine—lung cancer	0.000343	0.000439	CcSEcCtD
Rizatriptan—Hypersensitivity—Etoposide—lung cancer	0.000342	0.000438	CcSEcCtD
Rizatriptan—Erythema—Methotrexate—lung cancer	0.000341	0.000436	CcSEcCtD
Rizatriptan—Headache—Gemcitabine—lung cancer	0.000341	0.000436	CcSEcCtD
Rizatriptan—Dyspepsia—Docetaxel—lung cancer	0.00034	0.000435	CcSEcCtD
Rizatriptan—Hypoaesthesia—Doxorubicin—lung cancer	0.000338	0.000432	CcSEcCtD
Rizatriptan—Pharyngitis—Doxorubicin—lung cancer	0.000337	0.000431	CcSEcCtD
Rizatriptan—Decreased appetite—Docetaxel—lung cancer	0.000336	0.000429	CcSEcCtD
Rizatriptan—Hypersensitivity—Paclitaxel—lung cancer	0.000336	0.000429	CcSEcCtD
Rizatriptan—Dysgeusia—Methotrexate—lung cancer	0.000334	0.000427	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Docetaxel—lung cancer	0.000333	0.000427	CcSEcCtD
Rizatriptan—Asthenia—Etoposide—lung cancer	0.000333	0.000427	CcSEcCtD
Rizatriptan—Fatigue—Docetaxel—lung cancer	0.000333	0.000426	CcSEcCtD
Rizatriptan—Nausea—Irinotecan—lung cancer	0.000332	0.000425	CcSEcCtD
Rizatriptan—Pain—Docetaxel—lung cancer	0.00033	0.000422	CcSEcCtD
Rizatriptan—Constipation—Docetaxel—lung cancer	0.00033	0.000422	CcSEcCtD
Rizatriptan—Pruritus—Etoposide—lung cancer	0.000329	0.000421	CcSEcCtD
Rizatriptan—Asthenia—Paclitaxel—lung cancer	0.000327	0.000418	CcSEcCtD
Rizatriptan—Nausea—Gemcitabine—lung cancer	0.000323	0.000414	CcSEcCtD
Rizatriptan—Vomiting—Cisplatin—lung cancer	0.000322	0.000413	CcSEcCtD
Rizatriptan—Pruritus—Paclitaxel—lung cancer	0.000322	0.000412	CcSEcCtD
Rizatriptan—Vision blurred—Methotrexate—lung cancer	0.000321	0.000411	CcSEcCtD
Rizatriptan—Rash—Cisplatin—lung cancer	0.00032	0.000409	CcSEcCtD
Rizatriptan—Dermatitis—Cisplatin—lung cancer	0.000319	0.000409	CcSEcCtD
Rizatriptan—Feeling abnormal—Docetaxel—lung cancer	0.000318	0.000407	CcSEcCtD
Rizatriptan—Diarrhoea—Etoposide—lung cancer	0.000318	0.000407	CcSEcCtD
Rizatriptan—Tinnitus—Doxorubicin—lung cancer	0.000316	0.000405	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Docetaxel—lung cancer	0.000316	0.000404	CcSEcCtD
Rizatriptan—Flushing—Doxorubicin—lung cancer	0.000315	0.000403	CcSEcCtD
Rizatriptan—Diarrhoea—Paclitaxel—lung cancer	0.000312	0.000399	CcSEcCtD
Rizatriptan—Angiopathy—Doxorubicin—lung cancer	0.000308	0.000394	CcSEcCtD
Rizatriptan—Dizziness—Etoposide—lung cancer	0.000307	0.000393	CcSEcCtD
Rizatriptan—Vertigo—Methotrexate—lung cancer	0.000306	0.000392	CcSEcCtD
Rizatriptan—Body temperature increased—Docetaxel—lung cancer	0.000305	0.000391	CcSEcCtD
Rizatriptan—Abdominal pain—Docetaxel—lung cancer	0.000305	0.000391	CcSEcCtD
Rizatriptan—Chills—Doxorubicin—lung cancer	0.000304	0.000389	CcSEcCtD
Rizatriptan—Arrhythmia—Doxorubicin—lung cancer	0.000303	0.000388	CcSEcCtD
Rizatriptan—Dizziness—Paclitaxel—lung cancer	0.000301	0.000385	CcSEcCtD
Rizatriptan—Nausea—Cisplatin—lung cancer	0.000301	0.000385	CcSEcCtD
Rizatriptan—Cough—Methotrexate—lung cancer	0.000298	0.000381	CcSEcCtD
Rizatriptan—Mental disorder—Doxorubicin—lung cancer	0.000297	0.00038	CcSEcCtD
Rizatriptan—Convulsion—Methotrexate—lung cancer	0.000295	0.000378	CcSEcCtD
Rizatriptan—Vomiting—Etoposide—lung cancer	0.000295	0.000378	CcSEcCtD
Rizatriptan—Erythema—Doxorubicin—lung cancer	0.000295	0.000378	CcSEcCtD
Rizatriptan—Rash—Etoposide—lung cancer	0.000293	0.000375	CcSEcCtD
Rizatriptan—Dermatitis—Etoposide—lung cancer	0.000293	0.000374	CcSEcCtD
Rizatriptan—Headache—Etoposide—lung cancer	0.000291	0.000372	CcSEcCtD
Rizatriptan—Flatulence—Doxorubicin—lung cancer	0.000291	0.000372	CcSEcCtD
Rizatriptan—Arthralgia—Methotrexate—lung cancer	0.00029	0.000371	CcSEcCtD
Rizatriptan—Chest pain—Methotrexate—lung cancer	0.00029	0.000371	CcSEcCtD
Rizatriptan—Myalgia—Methotrexate—lung cancer	0.00029	0.000371	CcSEcCtD
Rizatriptan—Tension—Doxorubicin—lung cancer	0.00029	0.000371	CcSEcCtD
Rizatriptan—Vomiting—Paclitaxel—lung cancer	0.00029	0.000371	CcSEcCtD
Rizatriptan—Dysgeusia—Doxorubicin—lung cancer	0.000289	0.00037	CcSEcCtD
Rizatriptan—Rash—Paclitaxel—lung cancer	0.000287	0.000368	CcSEcCtD
Rizatriptan—Dermatitis—Paclitaxel—lung cancer	0.000287	0.000367	CcSEcCtD
Rizatriptan—Discomfort—Methotrexate—lung cancer	0.000287	0.000367	CcSEcCtD
Rizatriptan—Nervousness—Doxorubicin—lung cancer	0.000287	0.000367	CcSEcCtD
Rizatriptan—Headache—Paclitaxel—lung cancer	0.000285	0.000365	CcSEcCtD
Rizatriptan—Hypersensitivity—Docetaxel—lung cancer	0.000284	0.000364	CcSEcCtD
Rizatriptan—Muscle spasms—Doxorubicin—lung cancer	0.000284	0.000363	CcSEcCtD
Rizatriptan—Confusional state—Methotrexate—lung cancer	0.000281	0.000359	CcSEcCtD
Rizatriptan—Anaphylactic shock—Methotrexate—lung cancer	0.000278	0.000356	CcSEcCtD
Rizatriptan—Vision blurred—Doxorubicin—lung cancer	0.000278	0.000356	CcSEcCtD
Rizatriptan—Asthenia—Docetaxel—lung cancer	0.000277	0.000354	CcSEcCtD
Rizatriptan—Nausea—Etoposide—lung cancer	0.000276	0.000353	CcSEcCtD
Rizatriptan—Pruritus—Docetaxel—lung cancer	0.000273	0.00035	CcSEcCtD
Rizatriptan—Nervous system disorder—Methotrexate—lung cancer	0.000273	0.000349	CcSEcCtD
Rizatriptan—Agitation—Doxorubicin—lung cancer	0.000271	0.000347	CcSEcCtD
Rizatriptan—Nausea—Paclitaxel—lung cancer	0.000271	0.000346	CcSEcCtD
Rizatriptan—Hyperhidrosis—Methotrexate—lung cancer	0.000269	0.000344	CcSEcCtD
Rizatriptan—Vertigo—Doxorubicin—lung cancer	0.000265	0.000339	CcSEcCtD
Rizatriptan—Anorexia—Methotrexate—lung cancer	0.000265	0.000339	CcSEcCtD
Rizatriptan—Syncope—Doxorubicin—lung cancer	0.000265	0.000339	CcSEcCtD
Rizatriptan—Diarrhoea—Docetaxel—lung cancer	0.000264	0.000338	CcSEcCtD
Rizatriptan—Palpitations—Doxorubicin—lung cancer	0.000261	0.000334	CcSEcCtD
Rizatriptan—Loss of consciousness—Doxorubicin—lung cancer	0.00026	0.000332	CcSEcCtD
Rizatriptan—Cough—Doxorubicin—lung cancer	0.000258	0.00033	CcSEcCtD
Rizatriptan—Convulsion—Doxorubicin—lung cancer	0.000256	0.000327	CcSEcCtD
Rizatriptan—Dizziness—Docetaxel—lung cancer	0.000255	0.000327	CcSEcCtD
Rizatriptan—Hypertension—Doxorubicin—lung cancer	0.000255	0.000326	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000254	0.000324	CcSEcCtD
Rizatriptan—Insomnia—Methotrexate—lung cancer	0.000252	0.000322	CcSEcCtD
Rizatriptan—Arthralgia—Doxorubicin—lung cancer	0.000251	0.000322	CcSEcCtD
Rizatriptan—Myalgia—Doxorubicin—lung cancer	0.000251	0.000322	CcSEcCtD
Rizatriptan—Chest pain—Doxorubicin—lung cancer	0.000251	0.000322	CcSEcCtD
Rizatriptan—Anxiety—Doxorubicin—lung cancer	0.000251	0.000321	CcSEcCtD
Rizatriptan—Paraesthesia—Methotrexate—lung cancer	0.00025	0.00032	CcSEcCtD
Rizatriptan—Discomfort—Doxorubicin—lung cancer	0.000248	0.000318	CcSEcCtD
Rizatriptan—Dyspnoea—Methotrexate—lung cancer	0.000248	0.000317	CcSEcCtD
Rizatriptan—Somnolence—Methotrexate—lung cancer	0.000247	0.000317	CcSEcCtD
Rizatriptan—Dry mouth—Doxorubicin—lung cancer	0.000246	0.000315	CcSEcCtD
Rizatriptan—Vomiting—Docetaxel—lung cancer	0.000246	0.000314	CcSEcCtD
Rizatriptan—Dyspepsia—Methotrexate—lung cancer	0.000245	0.000313	CcSEcCtD
Rizatriptan—Rash—Docetaxel—lung cancer	0.000243	0.000312	CcSEcCtD
Rizatriptan—Dermatitis—Docetaxel—lung cancer	0.000243	0.000311	CcSEcCtD
Rizatriptan—Confusional state—Doxorubicin—lung cancer	0.000243	0.000311	CcSEcCtD
Rizatriptan—Decreased appetite—Methotrexate—lung cancer	0.000242	0.00031	CcSEcCtD
Rizatriptan—Headache—Docetaxel—lung cancer	0.000242	0.00031	CcSEcCtD
Rizatriptan—Oedema—Doxorubicin—lung cancer	0.000241	0.000308	CcSEcCtD
Rizatriptan—Anaphylactic shock—Doxorubicin—lung cancer	0.000241	0.000308	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Methotrexate—lung cancer	0.00024	0.000307	CcSEcCtD
Rizatriptan—Fatigue—Methotrexate—lung cancer	0.00024	0.000307	CcSEcCtD
Rizatriptan—Pain—Methotrexate—lung cancer	0.000238	0.000305	CcSEcCtD
Rizatriptan—Shock—Doxorubicin—lung cancer	0.000237	0.000303	CcSEcCtD
Rizatriptan—Nervous system disorder—Doxorubicin—lung cancer	0.000236	0.000302	CcSEcCtD
Rizatriptan—Tachycardia—Doxorubicin—lung cancer	0.000235	0.000301	CcSEcCtD
Rizatriptan—Hyperhidrosis—Doxorubicin—lung cancer	0.000233	0.000298	CcSEcCtD
Rizatriptan—Anorexia—Doxorubicin—lung cancer	0.00023	0.000294	CcSEcCtD
Rizatriptan—Nausea—Docetaxel—lung cancer	0.000229	0.000293	CcSEcCtD
Rizatriptan—Feeling abnormal—Methotrexate—lung cancer	0.000229	0.000293	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Methotrexate—lung cancer	0.000228	0.000291	CcSEcCtD
Rizatriptan—Urticaria—Methotrexate—lung cancer	0.000221	0.000283	CcSEcCtD
Rizatriptan—Abdominal pain—Methotrexate—lung cancer	0.00022	0.000281	CcSEcCtD
Rizatriptan—Body temperature increased—Methotrexate—lung cancer	0.00022	0.000281	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.00022	0.000281	CcSEcCtD
Rizatriptan—Insomnia—Doxorubicin—lung cancer	0.000218	0.000279	CcSEcCtD
Rizatriptan—Paraesthesia—Doxorubicin—lung cancer	0.000216	0.000277	CcSEcCtD
Rizatriptan—Dyspnoea—Doxorubicin—lung cancer	0.000215	0.000275	CcSEcCtD
Rizatriptan—Somnolence—Doxorubicin—lung cancer	0.000214	0.000274	CcSEcCtD
Rizatriptan—Dyspepsia—Doxorubicin—lung cancer	0.000212	0.000271	CcSEcCtD
Rizatriptan—Decreased appetite—Doxorubicin—lung cancer	0.000209	0.000268	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000208	0.000266	CcSEcCtD
Rizatriptan—Fatigue—Doxorubicin—lung cancer	0.000208	0.000266	CcSEcCtD
Rizatriptan—Constipation—Doxorubicin—lung cancer	0.000206	0.000264	CcSEcCtD
Rizatriptan—Pain—Doxorubicin—lung cancer	0.000206	0.000264	CcSEcCtD
Rizatriptan—Hypersensitivity—Methotrexate—lung cancer	0.000205	0.000262	CcSEcCtD
Rizatriptan—Asthenia—Methotrexate—lung cancer	0.0002	0.000255	CcSEcCtD
Rizatriptan—Feeling abnormal—Doxorubicin—lung cancer	0.000199	0.000254	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Doxorubicin—lung cancer	0.000197	0.000252	CcSEcCtD
Rizatriptan—Pruritus—Methotrexate—lung cancer	0.000197	0.000252	CcSEcCtD
Rizatriptan—Urticaria—Doxorubicin—lung cancer	0.000191	0.000245	CcSEcCtD
Rizatriptan—Abdominal pain—Doxorubicin—lung cancer	0.000191	0.000244	CcSEcCtD
Rizatriptan—Body temperature increased—Doxorubicin—lung cancer	0.000191	0.000244	CcSEcCtD
Rizatriptan—Diarrhoea—Methotrexate—lung cancer	0.00019	0.000244	CcSEcCtD
Rizatriptan—Dizziness—Methotrexate—lung cancer	0.000184	0.000235	CcSEcCtD
Rizatriptan—Hypersensitivity—Doxorubicin—lung cancer	0.000178	0.000227	CcSEcCtD
Rizatriptan—Vomiting—Methotrexate—lung cancer	0.000177	0.000226	CcSEcCtD
Rizatriptan—Rash—Methotrexate—lung cancer	0.000175	0.000225	CcSEcCtD
Rizatriptan—Dermatitis—Methotrexate—lung cancer	0.000175	0.000224	CcSEcCtD
Rizatriptan—Headache—Methotrexate—lung cancer	0.000174	0.000223	CcSEcCtD
Rizatriptan—Asthenia—Doxorubicin—lung cancer	0.000173	0.000221	CcSEcCtD
Rizatriptan—Pruritus—Doxorubicin—lung cancer	0.000171	0.000218	CcSEcCtD
Rizatriptan—Nausea—Methotrexate—lung cancer	0.000165	0.000212	CcSEcCtD
Rizatriptan—Diarrhoea—Doxorubicin—lung cancer	0.000165	0.000211	CcSEcCtD
Rizatriptan—Dizziness—Doxorubicin—lung cancer	0.000159	0.000204	CcSEcCtD
Rizatriptan—Vomiting—Doxorubicin—lung cancer	0.000153	0.000196	CcSEcCtD
Rizatriptan—Rash—Doxorubicin—lung cancer	0.000152	0.000194	CcSEcCtD
Rizatriptan—Dermatitis—Doxorubicin—lung cancer	0.000152	0.000194	CcSEcCtD
Rizatriptan—Headache—Doxorubicin—lung cancer	0.000151	0.000193	CcSEcCtD
Rizatriptan—Nausea—Doxorubicin—lung cancer	0.000143	0.000183	CcSEcCtD
Rizatriptan—HTR1A—Signaling by GPCR—MAP2K1—lung cancer	4.61e-05	0.000231	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AKT1—lung cancer	4.59e-05	0.00023	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HIF1A—lung cancer	4.58e-05	0.00023	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CD—lung cancer	4.58e-05	0.00023	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.58e-05	0.000229	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTA2—lung cancer	4.56e-05	0.000229	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CASP3—lung cancer	4.55e-05	0.000228	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL2—lung cancer	4.54e-05	0.000228	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOA1—lung cancer	4.52e-05	0.000226	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—lung cancer	4.52e-05	0.000226	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KDR—lung cancer	4.48e-05	0.000224	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCND1—lung cancer	4.42e-05	0.000222	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOA1—lung cancer	4.42e-05	0.000222	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—JUN—lung cancer	4.42e-05	0.000221	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AVP—lung cancer	4.41e-05	0.000221	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTA1—lung cancer	4.4e-05	0.000221	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CB—lung cancer	4.39e-05	0.00022	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KDR—lung cancer	4.38e-05	0.00022	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCC3—lung cancer	4.35e-05	0.000218	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CG—lung cancer	4.33e-05	0.000217	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP9—lung cancer	4.3e-05	0.000215	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CDKN1A—lung cancer	4.28e-05	0.000215	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PTEN—lung cancer	4.27e-05	0.000214	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1R—lung cancer	4.24e-05	0.000213	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL8—lung cancer	4.22e-05	0.000212	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKR1C1—lung cancer	4.22e-05	0.000211	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HES1—lung cancer	4.17e-05	0.000209	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AKT1—lung cancer	4.17e-05	0.000209	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APC—lung cancer	4.12e-05	0.000207	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KIT—lung cancer	4.12e-05	0.000207	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CG—lung cancer	4.12e-05	0.000207	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—NRAS—lung cancer	4.12e-05	0.000207	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—POMC—lung cancer	4.12e-05	0.000207	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—UGT1A1—lung cancer	4.09e-05	0.000205	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—RAF1—lung cancer	4.09e-05	0.000205	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGF—lung cancer	4.08e-05	0.000204	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EP300—lung cancer	4.07e-05	0.000204	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APC—lung cancer	4.04e-05	0.000202	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KIT—lung cancer	4.04e-05	0.000202	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CG—lung cancer	4.04e-05	0.000202	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—NRAS—lung cancer	4.04e-05	0.000202	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—IL2—lung cancer	4.04e-05	0.000202	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CREBBP—lung cancer	4.01e-05	0.000201	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGF—lung cancer	3.99e-05	0.0002	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CB—lung cancer	3.99e-05	0.0002	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SRC—lung cancer	3.96e-05	0.000199	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—MAPK3—lung cancer	3.95e-05	0.000198	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GNG11—lung cancer	3.95e-05	0.000198	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.93e-05	0.000197	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—POMC—lung cancer	3.93e-05	0.000197	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BRAF—lung cancer	3.88e-05	0.000194	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—MAPK3—lung cancer	3.87e-05	0.000194	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—lung cancer	3.86e-05	0.000193	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—POMC—lung cancer	3.84e-05	0.000193	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL8—lung cancer	3.83e-05	0.000192	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6R—lung cancer	3.83e-05	0.000192	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CREBBP—lung cancer	3.82e-05	0.000192	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—STAT3—lung cancer	3.82e-05	0.000191	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NRAS—lung cancer	3.81e-05	0.000191	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ERBB3—lung cancer	3.81e-05	0.000191	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CD—lung cancer	3.81e-05	0.000191	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BRAF—lung cancer	3.8e-05	0.00019	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EGFR—lung cancer	3.76e-05	0.000188	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALDOA—lung cancer	3.76e-05	0.000188	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALB—lung cancer	3.76e-05	0.000188	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6R—lung cancer	3.75e-05	0.000188	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CREBBP—lung cancer	3.74e-05	0.000188	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EGFR—lung cancer	3.68e-05	0.000184	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL2—lung cancer	3.66e-05	0.000184	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TERT—lung cancer	3.65e-05	0.000183	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAP2K1—lung cancer	3.65e-05	0.000183	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK3—lung cancer	3.65e-05	0.000183	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NCOA3—lung cancer	3.65e-05	0.000183	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CD—lung cancer	3.63e-05	0.000182	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PIK3CA—lung cancer	3.59e-05	0.00018	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.58e-05	0.00018	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAP2K1—lung cancer	3.57e-05	0.000179	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CD—lung cancer	3.55e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—KRAS—lung cancer	3.55e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MYC—lung cancer	3.55e-05	0.000178	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCG2—lung cancer	3.55e-05	0.000178	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADCY1—lung cancer	3.55e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGFR1—lung cancer	3.55e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CA—lung cancer	3.52e-05	0.000176	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HIF1A—lung cancer	3.49e-05	0.000175	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HPGDS—lung cancer	3.48e-05	0.000174	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ENO2—lung cancer	3.48e-05	0.000174	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—KRAS—lung cancer	3.48e-05	0.000174	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EGFR—lung cancer	3.47e-05	0.000174	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPP2R1B—lung cancer	3.46e-05	0.000173	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.41e-05	0.000171	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTT1—lung cancer	3.38e-05	0.000169	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOA1—lung cancer	3.37e-05	0.000169	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KDR—lung cancer	3.34e-05	0.000167	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GCLC—lung cancer	3.34e-05	0.000167	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2A6—lung cancer	3.34e-05	0.000167	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.32e-05	0.000167	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CB—lung cancer	3.32e-05	0.000166	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—lung cancer	3.29e-05	0.000165	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KRAS—lung cancer	3.28e-05	0.000164	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CA—lung cancer	3.26e-05	0.000163	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MDM2—lung cancer	3.25e-05	0.000163	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RAF1—lung cancer	3.24e-05	0.000162	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ERBB2—lung cancer	3.2e-05	0.000161	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CA—lung cancer	3.19e-05	0.00016	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MDM2—lung cancer	3.18e-05	0.000159	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RAF1—lung cancer	3.17e-05	0.000159	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ENO1—lung cancer	3.16e-05	0.000159	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MTOR—lung cancer	3.16e-05	0.000158	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CB—lung cancer	3.16e-05	0.000158	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.15e-05	0.000158	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ERBB2—lung cancer	3.14e-05	0.000157	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.11e-05	0.000156	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CB—lung cancer	3.09e-05	0.000155	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MTOR—lung cancer	3.09e-05	0.000155	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CG—lung cancer	3.08e-05	0.000154	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KIT—lung cancer	3.08e-05	0.000154	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APC—lung cancer	3.08e-05	0.000154	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—NRAS—lung cancer	3.08e-05	0.000154	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGF—lung cancer	3.04e-05	0.000152	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL8—lung cancer	3.04e-05	0.000152	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HRAS—lung cancer	3.02e-05	0.000151	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CA—lung cancer	3.01e-05	0.000151	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL8—lung cancer	2.97e-05	0.000149	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HRAS—lung cancer	2.95e-05	0.000148	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—MAPK3—lung cancer	2.95e-05	0.000148	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT1—lung cancer	2.93e-05	0.000147	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—POMC—lung cancer	2.93e-05	0.000147	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—lung cancer	2.91e-05	0.000146	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CASP3—lung cancer	2.91e-05	0.000146	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL2—lung cancer	2.9e-05	0.000145	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BRAF—lung cancer	2.89e-05	0.000145	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—lung cancer	2.89e-05	0.000145	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT1—lung cancer	2.87e-05	0.000144	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTEN—lung cancer	2.87e-05	0.000144	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6R—lung cancer	2.86e-05	0.000143	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CREBBP—lung cancer	2.85e-05	0.000143	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CASP3—lung cancer	2.85e-05	0.000143	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL2—lung cancer	2.84e-05	0.000142	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2E1—lung cancer	2.84e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCND1—lung cancer	2.83e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—lung cancer	2.83e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—JUN—lung cancer	2.82e-05	0.000142	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NQO1—lung cancer	2.8e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EGFR—lung cancer	2.8e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HRAS—lung cancer	2.79e-05	0.00014	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCND1—lung cancer	2.77e-05	0.000139	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—JUN—lung cancer	2.76e-05	0.000139	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—lung cancer	2.75e-05	0.000138	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.75e-05	0.000138	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN1A—lung cancer	2.74e-05	0.000137	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—EP300—lung cancer	2.73e-05	0.000137	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTEN—lung cancer	2.73e-05	0.000137	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAP2K1—lung cancer	2.72e-05	0.000136	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.72e-05	0.000136	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CD—lung cancer	2.7e-05	0.000136	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—lung cancer	2.69e-05	0.000135	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN1A—lung cancer	2.68e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	2.68e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTEN—lung cancer	2.67e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—lung cancer	2.67e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT1—lung cancer	2.66e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—KRAS—lung cancer	2.65e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT1—lung cancer	2.61e-05	0.000131	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EP300—lung cancer	2.6e-05	0.000131	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EP300—lung cancer	2.55e-05	0.000128	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SRC—lung cancer	2.53e-05	0.000127	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—STK11—lung cancer	2.53e-05	0.000127	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SRC—lung cancer	2.48e-05	0.000124	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—lung cancer	2.47e-05	0.000124	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT1—lung cancer	2.46e-05	0.000123	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—STAT3—lung cancer	2.44e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NRAS—lung cancer	2.44e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	2.43e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MDM2—lung cancer	2.42e-05	0.000121	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—lung cancer	2.42e-05	0.000121	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RAF1—lung cancer	2.41e-05	0.000121	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—STAT3—lung cancer	2.39e-05	0.00012	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ERBB2—lung cancer	2.39e-05	0.00012	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NRAS—lung cancer	2.39e-05	0.00012	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.37e-05	0.000119	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CB—lung cancer	2.36e-05	0.000118	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MTOR—lung cancer	2.36e-05	0.000118	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTP1—lung cancer	2.34e-05	0.000117	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK3—lung cancer	2.33e-05	0.000117	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK3—lung cancer	2.28e-05	0.000115	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CAT—lung cancer	2.28e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MYC—lung cancer	2.27e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL8—lung cancer	2.27e-05	0.000114	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.26e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HRAS—lung cancer	2.25e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MYC—lung cancer	2.22e-05	0.000111	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGFR—lung cancer	2.22e-05	0.000111	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCB1—lung cancer	2.21e-05	0.000111	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT1—lung cancer	2.19e-05	0.00011	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TYMS—lung cancer	2.17e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGFR—lung cancer	2.17e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP3—lung cancer	2.17e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL2—lung cancer	2.17e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—lung cancer	2.15e-05	0.000108	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTM1—lung cancer	2.15e-05	0.000108	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCND1—lung cancer	2.11e-05	0.000106	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JUN—lung cancer	2.11e-05	0.000106	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KRAS—lung cancer	2.1e-05	0.000105	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KRAS—lung cancer	2.05e-05	0.000103	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—lung cancer	2.05e-05	0.000103	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN1A—lung cancer	2.04e-05	0.000102	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP1A1—lung cancer	2.04e-05	0.000102	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTEN—lung cancer	2.04e-05	0.000102	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CA—lung cancer	2.02e-05	0.000101	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ERCC2—lung cancer	2.02e-05	0.000101	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT1—lung cancer	1.99e-05	9.96e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EP300—lung cancer	1.94e-05	9.74e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CA—lung cancer	1.93e-05	9.66e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SRC—lung cancer	1.89e-05	9.47e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CA—lung cancer	1.89e-05	9.46e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—lung cancer	1.86e-05	9.34e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—lung cancer	1.84e-05	9.22e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—lung cancer	1.83e-05	9.15e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—STAT3—lung cancer	1.82e-05	9.13e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NRAS—lung cancer	1.82e-05	9.11e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HRAS—lung cancer	1.78e-05	8.94e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOA1—lung cancer	1.75e-05	8.77e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HRAS—lung cancer	1.75e-05	8.75e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK3—lung cancer	1.74e-05	8.73e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—lung cancer	1.71e-05	8.55e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MYC—lung cancer	1.69e-05	8.49e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.67e-05	8.39e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—lung cancer	1.67e-05	8.37e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGFR—lung cancer	1.66e-05	8.3e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKT1—lung cancer	1.65e-05	8.28e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CG—lung cancer	1.6e-05	8e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT1—lung cancer	1.57e-05	7.89e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KRAS—lung cancer	1.56e-05	7.84e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT1—lung cancer	1.54e-05	7.73e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—POMC—lung cancer	1.52e-05	7.62e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CREBBP—lung cancer	1.48e-05	7.42e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.44e-05	7.2e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CD—lung cancer	1.4e-05	7.03e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—lung cancer	1.39e-05	6.97e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALB—lung cancer	1.39e-05	6.94e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HRAS—lung cancer	1.33e-05	6.67e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—lung cancer	1.27e-05	6.38e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CB—lung cancer	1.22e-05	6.13e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—lung cancer	1.21e-05	6.08e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT1—lung cancer	1.17e-05	5.89e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTEN—lung cancer	1.06e-05	5.3e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—EP300—lung cancer	1.01e-05	5.05e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CA—lung cancer	7.46e-06	3.74e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKT1—lung cancer	6.09e-06	3.05e-05	CbGpPWpGaD
